| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-10 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-09 |